Demant A/S (OTCMKTS:WILYY) Cut to Hold at Sanford C. Bernstein

Demant A/S (OTCMKTS:WILYY) was downgraded by stock analysts at Sanford C. Bernstein from a “strong-buy” rating to a “hold” rating in a research note issued on Friday,Zacks.com reports.

Several other research firms have also recently issued reports on WILYY. Morgan Stanley raised shares of Demant A/S from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, June 23rd. Zacks Research raised shares of Demant A/S to a “hold” rating in a research report on Friday, June 26th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Demant A/S Stock Performance

WILYY opened at $20.66 on Friday. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.00 and a current ratio of 1.36. The business has a 50-day moving average of $19.43 and a two-hundred day moving average of $16.86. Demant A/S has a 12 month low of $13.45 and a 12 month high of $20.98.

Demant A/S Company Profile

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.